Literature DB >> 27282614

Is it time to take bare metal stents off the catheter laboratory shelf?

George Kassimis1, Adrian P Banning2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27282614      PMCID： PMC5841223          DOI： 10.1093/eurheartj/ehw215

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  26 in total

Review 1.  Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.

Authors:  Edoardo Camenzind; P Gabriel Steg; William Wijns
Journal:  Circulation       Date:  2007-03-07       Impact factor: 29.690

2.  Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.

Authors:  Fausto Feres; Ricardo A Costa; Alexandre Abizaid; Martin B Leon; J Antônio Marin-Neto; Roberto V Botelho; Spencer B King; Manuela Negoita; Minglei Liu; J Eduardo T de Paula; José A Mangione; George X Meireles; Hélio J Castello; Eduardo L Nicolela; Marco A Perin; Fernando S Devito; André Labrunie; Décio Salvadori; Marcos Gusmão; Rodolfo Staico; J Ribamar Costa; Juliana P de Castro; Andrea S Abizaid; Deepak L Bhatt
Journal:  JAMA       Date:  2013-12-18       Impact factor: 56.272

Review 3.  Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary.

Authors:  Robert A Byrne; Patrick W Serruys; Andreas Baumbach; Javier Escaned; Jean Fajadet; Stefan James; Michael Joner; Semih Oktay; Peter Jüni; Adnan Kastrati; George Sianos; Giulio G Stefanini; William Wijns; Stephan Windecker
Journal:  Eur Heart J       Date:  2015-06-12       Impact factor: 29.983

4.  Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

Authors:  Dean J Kereiakes; Robert W Yeh; Joseph M Massaro; Priscilla Driscoll-Shempp; Donald E Cutlip; P Gabriel Steg; Anthony H Gershlick; Harald Darius; Ian T Meredith; John Ormiston; Jean Francois Tanguay; Stephan Windecker; Kirk N Garratt; David E Kandzari; David P Lee; Daniel I Simon; Adrian Corneliu Iancu; Jaroslaw Trebacz; Laura Mauri
Journal:  JAMA       Date:  2015-03-17       Impact factor: 56.272

5.  Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.

Authors:  Manel Sabaté; Lorenz Räber; Dik Heg; Salvatore Brugaletta; Henning Kelbaek; Angel Cequier; Miodrag Ostojic; Andrés Iñiguez; David Tüller; Antonio Serra; Andreas Baumbach; Clemens von Birgelen; Rosana Hernandez-Antolin; Marco Roffi; Vicente Mainar; Marco Valgimigli; Patrick W Serruys; Peter Jüni; Stephan Windecker
Journal:  JACC Cardiovasc Interv       Date:  2013-12-11       Impact factor: 11.195

6.  A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly).

Authors:  Adam de Belder; Jose M de la Torre Hernandez; Ramon Lopez-Palop; Peter O'Kane; Felipe Hernandez Hernandez; Julian Strange; Federico Gimeno; James Cotton; Jose F Diaz Fernandez; Pilar Carrillo Saez; Martyn Thomas; Eduardo Pinar; Nick Curzen; Jose A Baz; Nina Cooter; Inigo Lozano; Nicola Skipper; Derek Robinson; David Hildick-Smith
Journal:  J Am Coll Cardiol       Date:  2013-11-21       Impact factor: 24.094

7.  Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.

Authors:  Mary T Hawn; Laura A Graham; Joshua S Richman; Kamal M F Itani; William G Henderson; Thomas M Maddox
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

8.  Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.

Authors:  Sigmund Silber; Ajay J Kirtane; Jorge A Belardi; Minglei Liu; Sandeep Brar; Martin Rothman; Stephan Windecker
Journal:  Eur Heart J       Date:  2014-02-07       Impact factor: 29.983

9.  Perioperative Cardiovascular Risk of Prior Coronary Stent Implantation Among Patients Undergoing Noncardiac Surgery.

Authors:  Karim D Mahmoud; Saurabh Sanon; Elizabeth B Habermann; Ryan J Lennon; Kristine M Thomsen; Douglas L Wood; Felix Zijlstra; Robert L Frye; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2016-03-08       Impact factor: 24.094

10.  Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial.

Authors:  Manel Sabaté; Salvatore Brugaletta; Angel Cequier; Andrés Iñiguez; Antonio Serra; Pilar Jiménez-Quevedo; Vicente Mainar; Gianluca Campo; Maurizio Tespili; Peter den Heijer; Armando Bethencourt; Nicolás Vazquez; Gerrit Anne van Es; Bianca Backx; Marco Valgimigli; Patrick W Serruys
Journal:  Lancet       Date:  2015-10-29       Impact factor: 79.321
View more
  3 in total

1.  Double-vessel very late stent thrombosis following Resolute Onyx zotarolimus eluting stents implantation in an octogenarian.

Authors:  George Kassimis; Tushar Raina
Journal:  J Geriatr Cardiol       Date:  2018-10       Impact factor: 3.327

2.  Endovascular procedures cause transient endothelial injury but do not disrupt mature neointima in Drug Eluting Stents.

Authors:  Anouchska Autar; Aladdin Taha; Richard van Duin; Ilona Krabbendam-Peters; Dirk J Duncker; Felix Zijlstra; Heleen M M van Beusekom
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

3.  Should Percutaneous Coronary Intervention be the Standard Treatment Strategy for Significant Coronary Artery Disease in all Octogenarians?

Authors:  George Kassimis; Grigoris V Karamasis; Athanasios Katsikis; Joanna Abramik; Nestoras Kontogiannis; Matthaios Didagelos; Dimitrios Petroglou; Christodoulos E Papadopoulos; Leonidas Poulimenos; Vassilios Vassilikos; Ioannis Kanonidis; Tushar Raina; Antonios Ziakas
Journal:  Curr Cardiol Rev       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.